Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-28 @ 1:06 AM
Study NCT ID:
NCT03991403
Status:
UNKNOWN
Last Update Posted:
2023-04-03
First Post:
2019-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Sponsor:
Samsung Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-small Cell Lung Cancer | View |
Keywords: